4 employees
Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism.
1998
$20M
from 2 investors over 2 rounds
Koronis Pharma raised $20M on June 28, 2007
Investors: Pacific Horizon Ventures and Asset Management Ventures